Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma
NCT05622136
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Liver Cancer
Hepatocellular Carcinoma
Interventions
DRUG:
Regorafenib Oral Product
Sponsor
Instituto do Cancer do Estado de São Paulo